亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Improving the bioavailability of pharmacologically active substances in pharmaceutical and cosmetic formulations

        2017-01-19 11:37:40

        aFraunhofer Institute Applied Polymer Research(IAP),14476 Potsdam,Germany

        bBeuth University Applied Sciences,13353 Berlin,Germany

        Improving the bioavailability of pharmacologically active substances in pharmaceutical and cosmetic formulations

        Joachim Storsberga,*,Marcel W.Laughtona,b,Martin Geyera,b, Mont Kumpugdee-Vollrathb,Christian Schmidta

        aFraunhofer Institute Applied Polymer Research(IAP),14476 Potsdam,Germany

        bBeuth University Applied Sciences,13353 Berlin,Germany

        A R T I C L E I N F O

        Article history:

        Available online 23 November 2015

        Drug delivery

        Bioavailability

        Nano carriers

        Cosmeceutical

        Galenicals

        One and the same active ingredient can be used in different pharmaceutical applications to treat and cure diseases.Furthermore,the active ingredient can be used also in cosmetic formulations to care or aid the healing process.When applied topically via creams or lotions,they are referred as cosmeceuticals.In general,one aims to improve the bioavailability through tailored formulations and careful selection of components.An example is the use of latanoprost in ophthalmology for lowering the intraocular pressure in glaucoma patients with side effects including stimulated growth of eyelashes.Does this open up the possibility of using latanoprost for the local treatment for hair loss?

        Latanoprost,when applied topically,shows a stimulating effect on the growth of eyelashes[1]and could serve as an agent against extensive hair loss.Hyaluronic acid is an active component which is selectively used against early skin aging[2]. The objective of this work was to establish surfactant stabilized cosmetic formulations and create galenicals based on latanoprost and creams based on hyaluronic acid.

        Tococpherol was incorporated into lecithin based liposomes.Tocopherol served as a model substance for a lipophilic pharmacologically active ingredient.Using standard methods, such as thin-flm hydration method,followed by and ultrasound-assisted formation of liposomes[3],we createdparticles of the desired size range.Hyaluronic acid was incorporated into various cream bases and viscosities were measured at varying temperatures.Latanoprost based foam preparations were established and investigated with regard to foam stability.

        Fig.1–Figure left:Left upper panel:Artistic interpretation of a liposome-based drug carrier.Right upper panel:Tissue treated with a polymer based immune-histological test.Tumor tissue is stained in brown color(specifc staining)with a blue counterstaining of the surrounding tissue(unspecifc staining).Bottom panel:Phase contrast photograph of exponentially growing carcinoma cells(HCT-116:size bar:200 μm).This fgure was previously published in ref.[3].Figure right:Different phospholipids used in liposome formulations.

        Aside from liposomes,charged polymers that are able to bind and/or“complex”a drug are suitable for improving drug delivery systems as well as for the generation of new pharmaceuticals and cosmeceuticals.

        Acknowledgement

        The authors acknowledge fnancial support from the Fraunhofer Society through the ICON project“Drug Delivery.”

        R E F E R E N C E S

        [1]Sugimoto M,Sugimoto M,Uji Y.Quantitative analysis of eyelash lengthening following topical latanoprost therapy. Can J Ophthalmol 2002;37:342–345.

        [2]Vetter L,Laughton MW,Schmidt C,et al.Anti-ageing creams, ingredients and their effects against early skin ageing.SOFW J 2014;140:32–39.SOFW J(English Edition)2014;140:34–9.

        [3]Schmidt C,Storsberg J.Nanomaterials–tools,technology and methodology of nanotechnology based biomedical systems for diagnostics and therapy.Biomedicines 2015;3:203–223.

        *E-mail:joachim.storsberg@iap.fraunhofer.de.

        Peer review under responsibility of Shenyang Pharmaceutical University.

        http://dx.doi.org/10.1016/j.ajps.2015.10.022

        1818-0876/?2016 The Authors.Production and hosting by Elsevier B.V.on behalf of Shenyang Pharmaceutical University.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).

        欧美日韩不卡合集视频| 国产不卡在线观看视频| 亚洲中文字幕日产无码| 东北妇女xx做爰视频| 久久国产偷| 精品国产一区二区三区久久狼 | 欧美丰满熟妇xxxx性| 97se在线| 国产精品女同一区二区久| 91精品国产一区国产二区久久| 少妇高潮一区二区三区99| 国产高潮刺激叫喊视频| 亚洲av无码第一区二区三区| 亚洲av无码成人精品区天堂| 成年女人片免费视频播放A | 亚洲日本中文字幕乱码在线| 7777色鬼xxxx欧美色妇| 天堂sv在线最新版在线| 在线观看网址你懂的| 人妖与人妖免费黄色片| 人人澡人人妻人人爽人人蜜桃麻豆| 中文字幕精品一二三四五六七八| 日韩丝袜亚洲国产欧美一区| 亚洲一区二区三区精彩视频| 亚洲性色av一区二区三区| 疯狂做受xxxx高潮欧美日本| 天堂Av无码Av一区二区三区| 人妻有码av中文幕久久| 国语对白福利在线观看| 亚洲av无码专区在线播放中文 | 亚洲高清有码在线观看| 亚洲视频一区二区蜜桃| av在线播放男人天堂| 中文无码久久精品| 99久久超碰中文字幕伊人| 久久精品人妻中文av| 久久精品www人人爽人人| 日韩中文字幕欧美亚洲第一区| 久久精品国产88久久综合 | 中文字幕精品永久在线| 淫片一区二区三区av|